Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

People with alopecia have a higher risk of thyroid cancer.

New insights in skin conditions show a complex link between certain moles and melanoma, improved hair loss treatments, and the need to identify different types of lupus.

The conclusion is that finasteride is linked to an increased risk of suicidal thoughts and a higher risk of completed suicide when used for hair loss.

Researchers found potential new targets for treating melanoma and nonmelanoma skin cancers, and identified a possible cause and treatment for male pattern baldness and eczema.

Men and women with diabetes in Jeddah, Saudi Arabia, experience different symptoms and complications.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Societal pressure for the perfect body leads to health risks and disorders.

Skin problems like psoriasis and systemic sclerosis can increase the risk of heart disease, so doctors should watch for heart risks in patients with these conditions.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Older men's scalp damage increases with age and sun exposure, a baby girl in the Philippines has Schimmelpenning syndrome, and thyroid screening is advised for children with hair loss and certain risk factors.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Some psychoactive drugs can cause skin reactions, with carbamazepine having a higher risk, and stopping the drug and seeing a dermatologist is important.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Medical tattooing improves appearance and quality of life, but has potential risks.